LOGO
LOGO

Upgrading Reliance Steel & Aluminum To Buy, Increasing Estimates - KeyBanc Capital Comments

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Monday, KeyBanc Capital upgraded Reliance Steel & Aluminum Co. (RS) shares to Buy from Hold with a price target of $54. The brokerage increased its 2009 EPS estimate to $1.35 from $0.85, and its 2010 estimate to $2.85 from $2.60.

Analyst Mark Parr upgraded the stock in light of more broad-based demand stabilization and internal execution. The analyst established a price target of $54, which represents 10x EV/EBITDA on his 2010 outlook.

Although this falls above the high end of a historical normalized 5-8x range, the analyst views 2010 as indicative of the early stages of macro recovery. Further, RS shares traded at an average multiple of 10x during the 2001-2003 downturn. The analyst's improved near-term view yields stronger third quarter/fourth quarter bottom line recovery relative to his prior estimates and consensus.

The analyst senses RS is poised to benefit from increased potential for more broad-based demand recovery emerging over the next several quarters, substantial resolution of inventory mismatches, and restoration of more normalized FIFO gross margins, which strongly emerged during July and could be further enhanced over the balance of 2009.

Currently, RS is up $0.24 or 0.56% and trading at $42.84.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19